Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma. | J Cancer Res Ther | 2023 | 37147963 | PubTator, text mining | PubMed |
| Papillary renal neoplasm with reverse polarity: A case report. | Front Oncol | 2023 | 37143937 | PubTator, text mining | PubMed |
| Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells. | Signal Transduct Target Ther | 2023 | 37121942 | PubTator, text mining | PubMed |
| Metastatic lung tumor from hepatocellular carcinoma with tumor thrombus invasion in the pulmonary vein: a case report. | J Cardiothorac Surg | 2023 | 37118823 | PubTator, text mining | PubMed |
| Eosinophilic solid and cystic renal cell carcinoma with TSC2 mutation: a case report and literature review. | Diagn Pathol | 2023 | 37098579 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals an Eicosapentaenoic Acid Accumulation Mechanism in a Schizochytrium sp. Mutant. | Microbiol Spectr | 2023 | 37093006 | PubTator, text mining | PubMed |
| Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment. | Front Genet | 2023 | 37091783 | PubTator, text mining | PubMed |
| Durable Response to Pazopanib in a Patient with Fumarate Hydratase-Mutant Tubulocystic Renal Cell Carcinoma. | Case Rep Oncol | 2023 | 37069897 | PubTator, text mining | PubMed |
| [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2023 | 37042138 | PubTator, text mining | PubMed |
| Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas. | Cureus | 2023 | 37041930 | PubTator, text mining | PubMed |
| Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium. | BMC Cancer | 2023 | 37041497 | PubTator, text mining | PubMed |
| Using multi-tissue transcriptome-wide association study to identify candidate susceptibility genes for respiratory infectious diseases. | Front Genet | 2023 | 37020999 | PubTator, text mining | PubMed |
| DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMICAL EXPRESSION OF KI!67, P63 AND AMACR IN PROSTATE INTRAEPITHELIAL NEOPLASIA. | Wiad Lek | 2023 | 37010182 | PubTator, text mining | PubMed |
| GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer. | Technol Cancer Res Treat | 2023 | 36999196 | PubTator, text mining | PubMed |
| Behavioral variant frontotemporal dementia in a 23-year-old man. | Neurocase | 2023 | 36998234 | PubTator, text mining | PubMed |
| The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 | 36994114 | PubTator, text mining | PubMed |
| Programmable Nanostructures Based on Framework-DNA for Applications in Biosensing. | Sensors (Basel) | 2023 | 36992023 | PubTator, text mining | PubMed |
| The Potential Use of Exosomes in Anti-Cancer Effect Induced by Polarized Macrophages. | Pharmaceutics | 2023 | 36986884 | PubTator, text mining | PubMed |
| Systematic Review on the Metabolic Interest of Glucosinolates and Their Bioactive Derivatives for Human Health. | Nutrients | 2023 | 36986155 | PubTator, text mining | PubMed |
| Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging. | Cancers (Basel) | 2023 | 36980602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=13